The Patent Finder
US

Compositions for Treatment of Attention Deficit Hyperactivity Disorder

US 9,283,214 In force
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Jan 23, 2017 (U.S. Bank National Association).

Term ends Mar 23, 2032 · Medium confidence

Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 9,119,809), so the cap could be lower.

Filed May 5, 2015 as application 14/704,836 · Granted Mar 15, 2016
Base term, 20 years from filing
Today
20 years from filing
2012 2032
Clock starts
Mar 23, 2012
Term ends
Mar 23, 2032
Granted
Mar 15, 2016
base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,119,809, US 9,289,394, US 9,603,808, US 9,603,809, to Mar 23, 2032. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
25
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Mar 23, 2012, when application 13/429,292, the earliest non-provisional in its chain, was filed (this one was filed May 5, 2015)Mar 23, 2032High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 9,119,809, US 9,289,394, US 9,603,808, US 9,603,809)resolves to Mar 23, 2032, no earlier than this term, so no changeMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderMar 23, 2032Medium confidence

This family

US 9,028,868In force
no later than Mar 2032
no later than Mar 2032
US 8,927,010In force
no later than Mar 2032
no later than Mar 2032
US 8,916,588In force
no later than Mar 2032
no later than Mar 2032
US 9,119,809In force
no later than Mar 2032
no later than Mar 2032
US 9,034,902In force
no later than Mar 2032
no later than Mar 2032
US 9,023,389In force
no later than Mar 2032
no later than Mar 2032
US 9,283,214this patent
Mar 2032
Mar 2032
US 9,603,808In force
Mar 2032
Mar 2032
8 of 25 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jun 30, 2015
Reel 35941, frame 619
Zhang, FengFormulation Technologies, LLC Dba Pharmaform LLCAssignment of Assignor's Interest
Jun 30, 2015
Reel 35941, frame 702
Highland Therapeutics, Inc.Ironshore Pharmaceuticals & Development, Inc.Assignment of Assignor's Interest
Jun 30, 2015
Reel 35941, frame 726
Lickrish, DavidIronshore Pharmaceuticals & Development, Inc.Assignment of Assignor's Interest
Jun 30, 2015
Reel 36040, frame 783
Formulation Technologies L.L.C. Dba PharmaformHighland Therapeutics Inc.Assignment of Assignor's Interest
Jul 21, 2015
Reel 36140, frame 149
Ironshore Pharmaceuticals & Development, Inc.Eastern Capital LimitedPatent Security Agreement
Jan 23, 2017
Reel 41047, frame 474
Eastern Capital LimitedIronshore Pharmaceuticals & Development, Inc.Release of Security Interest
Jan 23, 2017
Reel 41048, frame 299
Ironshore Pharmaceuticals & Development, Inc.; Highland Therapeutics Inc.; North Sound Pharmaceuticals, Inc.; Ironshore Pharmaceuticals Inc.U.S. Bank National AssociationSecurity Interest
Sep 3, 2024
Reel 68826, frame 711
Ironshore Pharmaceuticals & Development, Inc.Biopharma Credit PLCPatent Security Agreement
Dec 5, 2025
Reel 73133, frame 245
U.S. Bank Trust Company, National AssociationIronshore Pharmaceuticals & Development, Inc.; Highland Therapeutics Inc.; North Sound Pharmaceuticals, Inc.; Ironshore Pharmaceuticals Inc.Release of Security Interest
Dec 5, 2025
reel/frame not recorded
U.S. Bank Trust Company, National AssociationIronshore Pharmaceuticals & Development, Inc.Release of Security Interest
Dec 5, 2025
reel/frame not recorded
U.S. Bank Trust Company, National AssociationHighland Therapeutics Inc.Release of Security Interest
Dec 5, 2025
reel/frame not recorded
U.S. Bank Trust Company, National AssociationNorth Sound Pharmaceuticals, Inc.Release of Security Interest
Dec 5, 2025
reel/frame not recorded
U.S. Bank Trust Company, National AssociationIronshore Pharmaceuticals Inc.Release of Security Interest
Dec 23, 2025
Reel 73302, frame 334
Collegium Pharmaceutical, Inc.; Biodelivery Sciences International, Inc.; Ironshore Pharmaceuticals & Development, Inc.Truist Bank, a North Carolina Chartered BankSecurity Interest
Dec 23, 2025
Reel 73308, frame 416
Biopharma Credit PLCIronshore Pharmaceuticals & Development, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited